- Home
- PRTA vs EQBK Comparison
PRTA vs EQBK Comparison
Compare PRTA & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- EQBK
- Stock Information
- Founded
- PRTA 2012
- EQBK 2002
- Country
- PRTA Ireland
- EQBK United States
- Employees
- PRTA N/A
- EQBK N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- PRTA Health Care
- EQBK Finance
- Exchange
- PRTA Nasdaq
- EQBK Nasdaq
- Market Cap
- PRTA 809.8M
- EQBK 763.9M
- IPO Year
- PRTA N/A
- EQBK 2015
- Fundamental
- Price
- PRTA $15.27
- EQBK $39.89
- Analyst Decision
- PRTA Buy
- EQBK Hold
- Analyst Count
- PRTA 9
- EQBK 5
- Target Price
- PRTA $54.57
- EQBK $45.60
- AVG Volume (30 Days)
- PRTA 396.4K
- EQBK 52.7K
- Earning Date
- PRTA 05-07-2025
- EQBK 04-15-2025
- Dividend Yield
- PRTA N/A
- EQBK 1.51%
- EPS Growth
- PRTA N/A
- EQBK 700.00
- EPS
- PRTA N/A
- EQBK 4.00
- Revenue
- PRTA $135,157,000.00
- EQBK $220,307,000.00
- Revenue This Year
- PRTA N/A
- EQBK $8.26
- Revenue Next Year
- PRTA $106.71
- EQBK $6.39
- P/E Ratio
- PRTA N/A
- EQBK $9.95
- Revenue Growth
- PRTA 47.92
- EQBK 59.51
- 52 Week Low
- PRTA $11.70
- EQBK $30.44
- 52 Week High
- PRTA $30.86
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- PRTA 54.26
- EQBK 29.20
- Support Level
- PRTA $13.89
- EQBK $40.21
- Resistance Level
- PRTA $16.16
- EQBK $43.78
- Average True Range (ATR)
- PRTA 1.14
- EQBK 1.08
- MACD
- PRTA 0.04
- EQBK -0.35
- Stochastic Oscillator
- PRTA 53.11
- EQBK 14.04
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.